ARCTArcturus Therapeutics Holdings Inc.
What is the market doing?
No clear lean: nothing decisive, though a crowded short (+19% of shares).
Choppy, but holding above its 200-day average. Oversold (RSI 21). Price is +10% vs its 200-day average.
A crowded short, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ARCT is trading
Arcturus Therapeutics Holdings Inc. is −15% over the past year while the S&P 500 is +16%: 31 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +10%
vs 200-day average · a clear uptrend
- RSI (14)
- 21
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 42%
Below its 52-week high
Details›
- Last close2026-10-23
- $9.83
- 1 monthS&P 500 −0.94%
- −30%
- 1 yearS&P 500 +16%
- −15%
- 5 yearsS&P 500 +86%
- −78%
- vs 50-day average$13.40
- −27%
- 52-week high
- $16.95
- 52-week low
- $5.52
- Annualised volatility
- 88%
| Year | Return |
|---|---|
| 2026 (year to date) | +60% |
| 2025 | −64% |
| 2024 | −46% |
| 2023 | +86% |
| 2022 | −54% |
| 2021 | −15% |
| 2020 | +299% |
| 2019 | +140% |
| 2018 | −43% |
| 2017 | −46% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +4.1% |
| Feb | 10 | 5 of 10 | +0.02% |
| Mar | 10 | 3 of 10 | +0.13% |
| Apr | 10 | 6 of 10 | +14% |
| May | 10 | 5 of 10 | +4.3% |
| Jun | 10 | 7 of 10 | +5.1% |
| Jul | 11 | 4 of 11 | +4.2% |
| Aug | 11 | 5 of 11 | +19% |
| Sep | 11 | 4 of 11 | −6.8% |
| Oct | 11 | 4 of 11 | −7.4% |
| Nov | 10 | 6 of 10 | +5.5% |
| Dec | 10 | 2 of 10 | −8.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.